Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice

Fengxia Gao, Rui‐Xin Wu, Meiying Shen, +14

iScience

VaccinationCellular Immune ToleranceVaccine DevelopmentHumoral ResponseImmunology +5

Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants

Chao Hu, Meiying Shen, Xiaojian Han, +17

Genes & Diseases

Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants

Tingting Li, Xiaojian Han, Chenjian Gu, +43

Nature Communications

Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer

Shouping Xu, Qin Wang, Yujuan Kang, +9

Cancer Immunology Research

Immune Checkpoint MoleculesImmunologyImmunotherapyOncologyLong Non-coding Rna +15

IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities

Li Du, Yaru Nai, Meiying Shen, +6

Frontiers in Molecular Biosciences

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy

Dan Shu, Meiying Shen, Kang Li, +9

Annals of Medicine

Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium

Heather Callaway, Kathryn M. Hastie, Sharon L. Schendel, +59

Cell Reports

A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2

Xiaojian Han, Yingming Wang, Shenglong Li, +34

Frontiers in Immunology

Neutralizing AntibodiesViral DiagnosticsImmunologyViral Structural ProteinImmunotherapy +14

Association of depressive symptoms and sleep disturbances with survival among US adult cancer survivors

Ailin Lan, Han Li, Meiying Shen, +7

BMC Medicine

Identification of long-term survival-associated gene in breast cancer

Shipeng Ning, Hui Li, Kun Qiao, +10

Aging

Breast OncologyBreast Cancer PatientsMedicinePathologyCancer Genomics +9